Adrenalectomy for pheochromocytoma: Surgical outcomes and preoperative risk factors for hemodynamic instability.
adrenalectomy
hemodynamic instability
pheochromocytoma
Journal
International journal of urology : official journal of the Japanese Urological Association
ISSN: 1442-2042
Titre abrégé: Int J Urol
Pays: Australia
ID NLM: 9440237
Informations de publication
Date de publication:
15 Jul 2024
15 Jul 2024
Historique:
received:
16
03
2024
accepted:
01
07
2024
medline:
15
7
2024
pubmed:
15
7
2024
entrez:
15
7
2024
Statut:
aheadofprint
Résumé
Surgical resection for pheochromocytoma (PCC) is still challenging. This study assessed the perioperative outcomes of adrenalectomy for PCC and investigated the risk factors for intraoperative hemodynamic instability (HI). This retrospective study included 571 patients with adrenal tumors who underwent adrenalectomy at Kobe University Hospital and other related hospitals between April 2008 and October 2023. The perioperative outcomes of laparoscopic adrenalectomy were compared between PCC (n = 92) and non-PCC (n = 464) groups. In addition, we investigated several potential risk factors for intraoperative HI in patients with PCC (n = 107; open, n = 11; laparoscopic, n = 92; robot-assisted, n = 4). While patients with PCC had a significantly larger amount of blood loss in comparison to those with non-PCC (mean, 70 and 30 mL, respectively; p = 0.004), no significant difference was observed in the rate of perioperative grade ≥III complications (1.1% vs. 0.6%; p = 0.516), and no perioperative mortality was observed in either group. A tumor size of ≥40 mm, with preoperative hypertension and urinary metanephrines at a level ≥3 times the upper limit of the normal value, were found to be significant predictors of HI, with odds ratios of 2.74 (p = 0.025), 3.91 (p = 0.005), and 3.83 (p = 0.004), respectively. Our data suggest that laparoscopic adrenalectomy for PCC may be as safe as that for other types of adrenal tumors and that large tumors and hormonally active disease may be risk factors for intraoperative HI. The optimal perioperative management for PCC with these risk factors should be established.
Sections du résumé
BACKGROUND
BACKGROUND
Surgical resection for pheochromocytoma (PCC) is still challenging. This study assessed the perioperative outcomes of adrenalectomy for PCC and investigated the risk factors for intraoperative hemodynamic instability (HI).
METHODS
METHODS
This retrospective study included 571 patients with adrenal tumors who underwent adrenalectomy at Kobe University Hospital and other related hospitals between April 2008 and October 2023. The perioperative outcomes of laparoscopic adrenalectomy were compared between PCC (n = 92) and non-PCC (n = 464) groups. In addition, we investigated several potential risk factors for intraoperative HI in patients with PCC (n = 107; open, n = 11; laparoscopic, n = 92; robot-assisted, n = 4).
RESULTS
RESULTS
While patients with PCC had a significantly larger amount of blood loss in comparison to those with non-PCC (mean, 70 and 30 mL, respectively; p = 0.004), no significant difference was observed in the rate of perioperative grade ≥III complications (1.1% vs. 0.6%; p = 0.516), and no perioperative mortality was observed in either group. A tumor size of ≥40 mm, with preoperative hypertension and urinary metanephrines at a level ≥3 times the upper limit of the normal value, were found to be significant predictors of HI, with odds ratios of 2.74 (p = 0.025), 3.91 (p = 0.005), and 3.83 (p = 0.004), respectively.
CONCLUSIONS
CONCLUSIONS
Our data suggest that laparoscopic adrenalectomy for PCC may be as safe as that for other types of adrenal tumors and that large tumors and hormonally active disease may be risk factors for intraoperative HI. The optimal perioperative management for PCC with these risk factors should be established.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Japanese Urological Association.
Références
Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665–675.
Scholten A, Cisco RM, Vriens MR, Cohen JK, Mitmaker EJ, Liu C, et al. Pheochromocytoma crisis is not a surgical emergency. J Clin Endocrinol Metab. 2013;98:581–591.
Tiberio GA, Baiocchi GL, Arru L, Agabiti Rosei C, De Ponti S, Matheis A, et al. Prospective randomized comparison of laparoscopic versus open adrenalectomy for sporadic pheochromocytoma. Surg Endosc. 2008;22:1435–1439.
Ulchaker JC, Goldfarb DA, Bravo EL, Novick AC. Successful outcomes in pheochromocytoma surgery in the modern era. J Urol. 1999;161:764–767.
Flávio Rocha M, Faramarzi‐Roques R, Tauzin‐Fin P, Vallee V, Leitao de Vasconcelos PR, Ballanger P. Laparoscopic surgery for pheochromocytoma. Eur Urol. 2004;45:226–232.
Desmonts JM, le Houelleur J, Remond P, Duvaldestin P. Anaesthetic management of patients with phaeochromocytoma. A review of 102 cases. Br J Anaesth. 1977;49:991–998.
Li S, Li Z, Zheng J, Chen X. Risk factors and a predictive nomogram for hemodynamic instability during adrenalectomy for large pheochromocytomas and paragangliomas: a retrospective cohort study. Eur J Surg Oncol. 2023;49:106964.
Ma W, Mao Y, Zhuo R, Dai J, Fang C, Wang C, et al. Surgical outcomes of a randomized controlled trial compared robotic versus laparoscopic adrenalectomy for pheochromocytoma. Eur J Surg Oncol. 2020;46:1843–1847.
Wan S, Li K, Wang C, Chen S, Wang H, Luo Y, et al. Which surgical approach is more favorable for pheochromocytoma of different sizes (< 6 cm vs. ≥ 6 cm)? A single retrospective center experience. World J Surg Oncol. 2023;21:285.
Kalady MF, McKinlay R, Olson JA Jr, Pinheiro J, Lagoo S, Park A, et al. Laparoscopic adrenalectomy for pheochromocytoma. A comparison to aldosteronoma and incidentaloma. Surg Endosc. 2004;18:621–625.
Northcutt BG, Raman SP, Long C, Oshmyansky AR, Siegelman SS, Fishman EK, et al. MDCT of adrenal masses: can dual‐phase enhancement patterns be used to differentiate adenoma and Pheochromocytoma? Am J Roentgenol. 2013;201:834–839.
Li J, Wang Y, Chang X, Han Z. Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): a systematic review and meta‐analysis. Eur J Surg Oncol. 2020;46:991–998.
Gaujoux S, Bonnet S, Lentschener C, Thillois JM, Duboc D, Bertherat J, et al. Preoperative risk factors of hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma. Surg Endosc. 2016;30:2984–2993.
Bai S, Yao Z, Zhu X, Li Z, Jiang Y, Wang R, et al. Risk factors for postoperative severe morbidity after pheochromocytoma surgery: a single center retrospective analysis of 262 patients. Int J Surg. 2018;60:188–193.
Eisenhofer G, Deutschbein T, Constantinescu G, Langton K, Pamporaki C, Calsina B, et al. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma. Clin Chem Lab Med. 2020;59:353–363.
Balla A, Palmieri L, Meoli F, Corallino D, Ortenzi M, Ursi P, et al. Are adrenal lesions of 6 cm or more in diameter a contraindication to laparoscopic adrenalectomy? A case–control study. World J Surg. 2020;44:810–818.
Vorselaars W, Postma EL, Mirallie E, Thiery J, Lustgarten M, Pasternak JD, et al. Hemodynamic instability during surgery for pheochromocytoma: comparing the transperitoneal and retroperitoneal approach in a multicenter analysis of 341 patients. Surgery. 2018;163:176–182.
Jiang Y‐L, Qian L‐J, Li Z, Wang KE, Zhou XL, Zhou J, et al. Comparison of the retroperitoneal versus transperitoneal laparoscopic adrenalectomy perioperative outcomes and safety for Pheochromocytoma: a meta‐analysis. BMC Surg. 2020;20:12.
Fu SQ, Wang SY, Chen Q, Liu YT, Li ZL, Sun T. Laparoscopic versus open surgery for pheochromocytoma: a meta‐analysis. BMC Surg. 2020;20:167.
Xia Z, Li J, Peng L, Yang X, Xu Y, Li X, et al. Comparison of perioperative outcomes of robotic‐assisted vs laparoscopic adrenalectomy for pheochromocytoma: a meta‐analysis. Front Oncol. 2021;11:724287.
Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, et al. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer. 2011;18:97–111.
Sbardella E, Grossman AB. Pheochromocytoma: an approach to diagnosis. Best Pract Res Clin Endocrinol Metab. 2020;34:101346.
Takeda T, Hakozaki K, Yanai Y, Masuda T, Yasumizu Y, Tanaka N, et al. Risk factors for haemodynamic instability and its prolongation during laparoscopic adrenalectomy for pheochromocytoma. Clin Endocrinol. 2021;95:716–726.
De Filpo G, Parenti G, Sparano C, Rastrelli G, Rapizzi E, Martinelli S, et al. Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study. World J Surg Oncol. 2023;21:192.
Zawadzka K, Więckowski K, Małczak P, Wysocki M, Major P, Pędziwiatr M, et al. Selective vs non‐selective alpha‐blockade prior to adrenalectomy for pheochromocytoma: systematic review and meta‐analysis. Eur J Endocrinol. 2021;184:751–760.
Prys‐Roberts C, Farndon JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg. 2002;26:1037–1042.
Kocak S, Aydintug S, Canakci N. Alpha blockade in preoperative preparation of patients with pheochromocytomas. Int Surg. 2002;87:191–194.
Buitenwerf E, Osinga TE, Timmers HJLM, Lenders JWM, Feelders RA, Eekhoff EMW, et al. Efficacy of α‐blockers on hemodynamic control during pheochromocytoma resection: a randomized controlled trial. J Clin Endocrinol Metab. 2019;105:2381–2391.
Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, et al. Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi‐center trial in Japan. Endocr J. 2018;65:359–371.
Wachtel H, Kennedy EH, Zaheer S, Bartlett EK, Fishbein L, Roses RE, et al. Preoperative metyrosine improves cardiovascular outcomes for patients undergoing surgery for pheochromocytoma and paraganglioma. Ann Surg Oncol. 2015;22:S646–S654.